HomeCompareGEBHF vs JNJ

GEBHF vs JNJ: Dividend Comparison 2026

GEBHF yields 1.59% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $10.3K in total portfolio value· pulled ahead in Year 5
10 years
GEBHF
GEBHF
● Live price
1.59%
Share price
$0.63
Annual div
$0.01
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.9K
Annual income
$0.16
Full GEBHF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — GEBHF vs JNJ

📍 JNJ pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGEBHFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GEBHF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GEBHF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GEBHF
Annual income on $10K today (after 15% tax)
$134.92/yr
After 10yr DRIP, annual income (after tax)
$0.14/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, JNJ beats the other by $3,985.85/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GEBHF + JNJ for your $10,000?

GEBHF: 50%JNJ: 50%
100% JNJ50/50100% GEBHF
Portfolio after 10yr
$25.1K
Annual income
$2,344.78/yr
Blended yield
9.34%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

GEBHF
No analyst data
Altman Z
1.1
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GEBHF buys
0
JNJ buys
0
No recent congressional trades found for GEBHF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGEBHFJNJ
Forward yield1.59%2.13%
Annual dividend / share$0.01$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%28%
Portfolio after 10y$19.9K$30.3K
Annual income after 10y$0.16$4,689.40
Total dividends collected$159.00$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GEBHF vs JNJ ($10,000, DRIP)

YearGEBHF PortfolioGEBHF Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,779$79.37$10,592$272.30+$187.00GEBHF
2$11,574$39.98$11,289$357.73+$285.00GEBHF
3$12,404$20.06$12,123$472.89+$281.00GEBHF
4$13,282$10.05$13,141$629.86+$141.00GEBHF
5← crossover$14,217$5.03$14,408$846.81$191.00JNJ
6$15,215$2.51$16,021$1,151.60$806.00JNJ
7$16,281$1.26$18,122$1,588.22$1.8KJNJ
8$17,422$0.63$20,930$2,228.20$3.5KJNJ
9$18,641$0.31$24,792$3,191.91$6.2KJNJ
10$19,946$0.16$30,274$4,689.40$10.3KJNJ

GEBHF vs JNJ: Complete Analysis 2026

GEBHFStock

Genting Berhad, an investment holding company, engages in leisure and hospitality, oil palm plantation, power generation, oil and gas, property development and management, life sciences, and biotechnology businesses in Malaysia and internationally. Its Leisure & Hospitality segment is involved in gaming, hotels, food and beverages, theme parks, retail, entertainment and attractions, and tours and travel related businesses; the development and operation of resorts; and the provision of other support services. The company's Plantation segment operates oil palm plantations, and palm oil milling and related activities. Its Power segment generates and supplies electric power. The company's Property segment develops and invests in properties. Its Oil & Gas segment explores for, develops, and produces oil and gas. The company also offers offshore financing; advisory, technical, and administrative services to oil and gas companies; and risk and insurance management consultancy services, as well as issues private debt securities and licenses intellectual property rights. In addition, it manufactures and sells biodiesel; processes fresh fruit bunches; provides project management, technical, and other management services; and researches and develops technologies for genetic analysis and sequencing. Further, it creates platform for early diagnosis and treatment of Alzheimer's and other neurodegenerative diseases; and undertakes the collection, analysis, and testing of specimens, samples, and/or data for research and evaluation activities. Additionally, it engages in the provision of information technology services relating to the gaming and resort industry; and provision of international sales and marketing services, and corporate services. Genting Berhad was founded in 1965 and is headquartered in Kuala Lumpur, Malaysia.

Full GEBHF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this GEBHF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GEBHF vs SCHDGEBHF vs JEPIGEBHF vs OGEBHF vs KOGEBHF vs MAINGEBHF vs ABBVGEBHF vs MRKGEBHF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.